1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone
|
|
- Donna Owen
- 5 years ago
- Views:
Transcription
1 Report generated from BNF - Local Information provided by FormularyComplete ( Accessed Title Formulary Status Section Acidex 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Alginate raft-forming oral suspensions Adsorbents and bulk-forming drugs 1.4 Acute diarrhoea Altacite Plus Altacite Plus Alu-Cap 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->antacid containing simeticone antacids->aluminium HYDROXIDE->Aluminium-only Aluminium-only ALUMINIUM HYDROXIDE Antacid containing simeticone antacids->aluminium HYDROXIDE antacids 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone Anugesic-HC 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids Anusol-HC 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids Aprotinin 1.9 Drugs affecting intestinal secretions Aromatic Magnesium Carbonate Mixture, BP antacids->magnesium CARBONATE Asacol 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Asacol MR 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Atropine 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics->atropine SULFATE ATROPINE SULFATE 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics BECLOMETASONE DIPROPIONATE 1.5 Chronic bowel disorders->1.5.2 Corticosteroids
2 Celevac 1.6 Laxatives->1.6.1 Bulk-forming laxatives->methylcellulose Citramag 1.6 Laxatives->1.6.5 Bowel cleansing ->MAGNESIUM CITRATE Clipper 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->BECLOMETASONE DIPROPIONATE Co-magaldrox antacids->aluminium HYDROXIDE CO-PHENOTROPE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Co-phenotrope 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->co-phenotrope Compound Compound Compound 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics->dicycloverine HYDROCHLORIDE 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->mebeverine HYDROCHLORIDE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE Dentinox 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->simeticone alone Dipentum 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->OLSALAZINE SODIUM FAMOTIDINE 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists Famotidine 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->famotidine Fybogel Mebeverine Gastrocote Gaviscon Advance 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->mebeverine HYDROCHLORIDE->Compound 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate Hidrasec 1.4 Acute diarrhoea->1.4.3 Enkephalinase inhibitors->racecadotril HYDROTALCITE 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes Imodium Plus 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE->Compound Ipocol 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Ispagel Orange 1.6 Laxatives->1.6.1 Bulk-forming laxatives->ispaghula HUSK Kaolin and Morphine Mixture, BP 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->morphine
3 Kaolin Mixture, BP 1.4 Acute diarrhoea->1.4.1 Adsorbents and bulk-forming drugs->kaolin, LIGHT KAOLIN, LIGHT 1.4 Acute diarrhoea->1.4.1 Adsorbents and bulk-forming drugs Kolanticon 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics->dicycloverine HYDROCHLORIDE->Compound LIQUID PARAFFIN 1.6 Laxatives->1.6.3 Faecal softeners Liquid Paraffin and Magnesium Hydroxide Oral Emulsion, BP 1.6 Laxatives->1.6.4 Osmotic laxatives->magnesium SALTS->Magnesium hydroxide with liquid paraffin Maalox Plus Maalox 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->antacid containing simeticone antacids->aluminium HYDROXIDE->Co-magaldrox MAGNESIUM CARBONATE antacids MAGNESIUM CITRATE 1.6 Laxatives->1.6.5 Bowel cleansing Magnesium hydroxide 1.6 Laxatives->1.6.4 Osmotic laxatives->magnesium SALTS Magnesium hydroxide with liquid paraffin Magnesium Trisilicate Tablets, Compound, BP 1.6 Laxatives->1.6.4 Osmotic laxatives->magnesium SALTS antacids->magnesium TRISILICATE Manevac 1.6 Laxatives->1.6.2 Stimulant laxatives->senna METHYLCELLULOSE 1.6 Laxatives->1.6.1 Bulk-forming laxatives MORPHINE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Mucogel antacids->aluminium HYDROXIDE->Co-magaldrox NIZATIDINE 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists Nizatidine 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->nizatidine Normacol Plus 1.6 Laxatives->1.6.1 Bulk-forming laxatives->sterculia Normacol 1.6 Laxatives->1.6.1 Bulk-forming laxatives->sterculia Nutrizym Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength
4 OLSALAZINE SODIUM 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates Pancrease HL 1.9 Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength Pancrex 1.9 Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN PANTOPRAZOLE 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors Pantoprazole 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->pantoprazole Pariet 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->rabeprazole SODIUM Perinal 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids Picolax 1.6 Laxatives->1.6.5 Bowel cleansing ->SODIUM PICOSULFATE WITH MAGNESIUM CITRATE Pro-Banthine 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics->propantheline BROMIDE Proctofoam HC 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids PROPANTHELINE BROMIDE 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics Protium 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->pantoprazole Rabeprazole 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->rabeprazole SODIUM RABEPRAZOLE SODIUM 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors RACECADOTRIL 1.4 Acute diarrhoea->1.4.3 Enkephalinase inhibitors Rowachol 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow->other for biliary disorders Salofalk 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Selective antimuscarinics 1.3 Antisecretory drugs and mucosal protectants STERCULIA 1.6 Laxatives->1.6.1 Bulk-forming laxatives Ultraproct 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids Uniroid-HC 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids With ketoprofen 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->omeprazole With naproxen 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->esomeprazole ADALIMUMAB 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->cytokine modulators ALVERINE CITRATE 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics
5 Antepsin 1.3 Antisecretory drugs and mucosal protectants->1.3.3 Chelates and complexes->sucralfate ARACHIS OIL 1.6 Laxatives->1.6.3 Faecal softeners Arachis Oil Enema 1.6 Laxatives->1.6.3 Faecal softeners->arachis OIL AZATHIOPRINE 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response BALSALAZIDE SODIUM 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates Bile acid sequestrants 1.9 Drugs affecting intestinal secretions BISACODYL 1.6 Laxatives->1.6.2 Stimulant laxatives Bisacodyl 1.6 Laxatives->1.6.2 Stimulant laxatives->bisacodyl Budenofalk 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->BUDESONIDE BUDESONIDE 1.5 Chronic bowel disorders->1.5.2 Corticosteroids Buscopan 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics->hyoscine BUTYLBROMIDE CICLOSPORIN 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response CIMETIDINE 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists Cimetidine 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->cimetidine CitraFleet 1.6 Laxatives->1.6.5 Bowel cleansing ->SODIUM PICOSULFATE WITH MAGNESIUM CITRATE CODEINE PHOSPHATE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Colazide 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->BALSALAZIDE SODIUM COLESTYRAMINE 1.9 Drugs affecting intestinal secretions->1.9.2 Bile acid sequestrants Colifoam 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->HYDROCORTISONE Colofac 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->mebeverine HYDROCHLORIDE Colofac MR 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->mebeverine HYDROCHLORIDE->Modified release Colpermin 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->peppermint OIL Creon Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN Creon Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength Creon Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength Creon Micro 1.9 Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN
6 Cytokine modulators 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response Cytotec 1.3 Antisecretory drugs and mucosal protectants->1.3.4 Prostaglandin analogues->misoprostol De-Noltab 1.3 Antisecretory drugs and mucosal protectants->1.3.3 Chelates and complexes->tripotassium DICITRATOBISMUTHATE Dicycloverine 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics->dicycloverine HYDROCHLORIDE DICYCLOVERINE HYDROCHLORIDE 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics Dioctyl 1.6 Laxatives->1.6.2 Stimulant laxatives->docusate SODIUM DOCUSATE SODIUM 1.6 Laxatives->1.6.2 Stimulant laxatives Docusol 1.6 Laxatives->1.6.2 Stimulant laxatives->docusate SODIUM Entocort 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->BUDESONIDE Fleet Phospho-soda 1.6 Laxatives->1.6.5 Bowel cleansing ->PHOSPHATES (ORAL) Fleet Ready-to-use Enema 1.6 Laxatives->1.6.4 Osmotic laxatives->phosphates (RECTAL) Fybogel 1.6 Laxatives->1.6.1 Bulk-forming laxatives->ispaghula HUSK Gaviscon Infant Gaviscon 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Alginate raft-forming oral suspensions GLYCEROL 1.6 Laxatives->1.6.2 Stimulant laxatives Glycerol Suppositories, BP 1.6 Laxatives->1.6.2 Stimulant laxatives->glycerol GLYCERYL TRINITRATE 1.7 Local for anal and rectal disorders->1.7.4 Management of anal fissures GOLIMUMAB 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->cytokine modulators HYDROCORTISONE 1.5 Chronic bowel disorders->1.5.2 Corticosteroids HYOSCINE BUTYLBROMIDE 1.2 Antispasmodics and other drugs altering gut motility->antimuscarinics Imodium 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE Infacol 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->simeticone alone INFLIXIMAB 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->cytokine modulators
7 ISPAGHULA HUSK 1.6 Laxatives->1.6.1 Bulk-forming laxatives Klean-Prep 1.6 Laxatives->1.6.5 Bowel cleansing ->MACROGOLS LACTULOSE 1.6 Laxatives->1.6.4 Osmotic laxatives Lactulose 1.6 Laxatives->1.6.4 Osmotic laxatives->lactulose LANSOPRAZOLE 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors Lansoprazole 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->lansoprazole Loperamide 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Losec 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->omeprazole Macrogol Oral Powder, Compound 1.6 Laxatives->1.6.4 Osmotic laxatives->macrogols MACROGOLS 1.6 Laxatives->1.6.4 Osmotic laxatives MACROGOLS 1.6 Laxatives->1.6.5 Bowel cleansing MAGNESIUM SALTS 1.6 Laxatives->1.6.4 Osmotic laxatives Magnesium Sulfate 1.6 Laxatives->1.6.4 Osmotic laxatives->magnesium SALTS->Magnesium sulfate MAGNESIUM TRISILICATE Magnesium Trisilicate Mixture, BP MEBEVERINE HYDROCHLORIDE Mebeverine Hydrochloride antacids antacids->magnesium TRISILICATE 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->mebeverine HYDROCHLORIDE MERCAPTOPURINE 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response MESALAZINE 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates METHOTREXATE 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response Mezavant XL 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Mintec 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->peppermint OIL
8 MISOPROSTOL 1.3 Antisecretory drugs and mucosal protectants->1.3.4 Prostaglandin analogues Modified release 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->mebeverine HYDROCHLORIDE Movicol 1.6 Laxatives->1.6.4 Osmotic laxatives->macrogols Movicol -Half 1.6 Laxatives->1.6.4 Osmotic laxatives->macrogols Movicol Paediatric 1.6 Laxatives->1.6.4 Osmotic laxatives->macrogols Moviprep 1.6 Laxatives->1.6.5 Bowel cleansing ->MACROGOLS Nalcrom 1.5 Chronic bowel disorders->1.5.4 Food allergy->sodium CROMOGLICATE Octasa 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Oily Phenol Injection, BP 1.7 Local for anal and rectal disorders->1.7.3 Rectal sclerosants->phenol OMEPRAZOLE 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors Omeprazole 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->omeprazole Oral 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->PREDNISOLONE Pancreatin 1.9 Drugs affecting intestinal secretions Pancrex V 1.9 Drugs affecting intestinal secretions->1.9.4 Pancreatin->PANCREATIN Pentasa 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE PEPPERMINT OIL 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics Peptac 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Alginate raft-forming oral suspensions PHENOL 1.7 Local for anal and rectal disorders->1.7.3 Rectal sclerosants PHOSPHATES (ORAL) 1.6 Laxatives->1.6.5 Bowel cleansing PHOSPHATES (RECTAL) 1.6 Laxatives->1.6.4 Osmotic laxatives Phosphates Enema BP Formula B 1.6 Laxatives->1.6.4 Osmotic laxatives->phosphates (RECTAL) PREDNISOLONE 1.5 Chronic bowel disorders->1.5.2 Corticosteroids Prednisolone 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->PREDNISOLONE->Rectal Predsol 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->PREDNISOLONE->Rectal Preparations 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->azathioprine
9 Preparations 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->ciclosporin Preparations 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->mercaptopurine Preparations 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->methotrexate Preparations 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->cytokine modulators->adalimumab Preparations 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->cytokine modulators->infliximab Proctosedyl 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids PRUCALOPRIDE 1.6 Laxatives->1.6.7 Other drugs used in constipation RANITIDINE 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists Ranitidine 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->ranitidine Rectal 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->PREDNISOLONE Rectal 1.6 Laxatives->1.6.2 Stimulant laxatives->docusate SODIUM Rectal sclerosants 1.7 Local for anal and rectal disorders Rectogesic 1.7 Local for anal and rectal disorders->1.7.4 Management of anal fissures->glyceryl TRINITRATE Resolor 1.6 Laxatives->1.6.7 Other drugs used in constipation->prucalopride Salazopyrin 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->SULFASALAZINE Scheriproct 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids SENNA 1.6 Laxatives->1.6.2 Stimulant laxatives Senna 1.6 Laxatives->1.6.2 Stimulant laxatives->senna Senokot 1.6 Laxatives->1.6.2 Stimulant laxatives->senna SODIUM CITRATE (RECTAL) SODIUM CROMOGLICATE 1.6 Laxatives->1.6.4 Osmotic laxatives 1.5 Chronic bowel disorders->1.5.4 Food allergy SODIUM PICOSULFATE 1.6 Laxatives->1.6.2 Stimulant laxatives Sodium Picosulfate 1.6 Laxatives->1.6.2 Stimulant laxatives->sodium PICOSULFATE Soothing haemorrhoidal 1.7 Local for anal and rectal disorders
10 Spasmonal 1.2 Antispasmodics and other drugs altering gut motility->other antispasmodics->alverine CITRATE SUCRALFATE 1.3 Antisecretory drugs and mucosal protectants->1.3.3 Chelates and complexes SULFASALAZINE 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates Sulfasalazine 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->SULFASALAZINE Tagamet 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->cimetidine TRIPOTASSIUM DICITRATOBISMUTHATE 1.3 Antisecretory drugs and mucosal protectants->1.3.3 Chelates and complexes URSODEOXYCHOLIC ACID 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow Ursodeoxycholic Acid 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID Xyloproct 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids Zantac 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->ranitidine Zoton 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->lansoprazole Co-danthramer Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives->dantron->with poloxamer 188 (as co-danthramer) Co-danthrusate Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives->dantron->with docusate sodium (as co-danthrusate) DANTRON Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives ESOMEPRAZOLE Restricted 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors Esomeprazole Restricted 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->esomeprazole LINACLOTIDE Restricted 1.6 Laxatives->1.6.7 Other drugs used in constipation METHYLNALTREXONE BROMIDE Restricted 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists Nexium Restricted 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->esomeprazole Other drugs used in constipation Peripheral opioid-receptor antagonists Restricted Restricted 1.6 Laxatives 1.6 Laxatives Relistor Restricted 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists->methylnaltrexone BROMIDE
11 With docusate sodium (as co-danthrusate) With poloxamer 188 (as co-danthramer) Restricted Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives->dantron 1.6 Laxatives->1.6.2 Stimulant laxatives->dantron Amitiza 1.6 Laxatives->1.6.7 Other drugs used in constipation->lubiprostone CHOLIC ACID 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow Constella 1.6 Laxatives->1.6.7 Other drugs used in constipation->linaclotide Cortiment 1.5 Chronic bowel disorders->1.5.2 Corticosteroids->BUDESONIDE Destolit 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID diabact UBT 1.3 Antisecretory drugs and mucosal protectants->helicobacter pylori infection->test for Helicobacter pylori Entyvio 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->vedolizumab->vedolizumab Helicobacter Test INFAI Liquid Paraffin Oral Emulsion, BP 1.3 Antisecretory drugs and mucosal protectants->helicobacter pylori infection->test for Helicobacter pylori 1.6 Laxatives->1.6.3 Faecal softeners->liquid PARAFFIN LUBIPROSTONE 1.6 Laxatives->1.6.7 Other drugs used in constipation Magnesium Hydroxide Mixture, BP Micolette Micro-enema Micralax Micro-enema 1.6 Laxatives->1.6.4 Osmotic laxatives->magnesium SALTS->Magnesium hydroxide 1.6 Laxatives->1.6.4 Osmotic laxatives->sodium CITRATE (RECTAL) 1.6 Laxatives->1.6.4 Osmotic laxatives->sodium CITRATE (RECTAL) Moventig 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists->naloxegol NALOXEGOL 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists Norgalax Micro-enema 1.6 Laxatives->1.6.2 Stimulant laxatives->docusate SODIUM->Rectal Orphacol 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow->cholic ACID OsmoPrep 1.6 Laxatives->1.6.5 Bowel cleansing ->PHOSPHATES (ORAL) PANCREATIN 1.9 Drugs affecting intestinal secretions->1.9.4 Pancreatin Pylobactell 1.3 Antisecretory drugs and mucosal protectants->helicobacter pylori infection->test for Helicobacter pylori
12 Relaxit Micro-enema 1.6 Laxatives->1.6.4 Osmotic laxatives->sodium CITRATE (RECTAL) Revestive 1.5 Chronic bowel disorders->short bowel syndrome->teduglutide SODIUM PICOSULFATE WITH MAGNESIUM CITRATE 1.6 Laxatives->1.6.5 Bowel cleansing TEDUGLUTIDE 1.5 Chronic bowel disorders->short bowel syndrome Ursofalk 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID Ursogal 1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID VEDOLIZUMAB 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->vedolizumab
Report generated from MPH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number.
Report generated from MPH provided by Complete (www.pharmpress.com). Accessed 15 01 2016 Title Status Section TA Number TA Link Alu-Cap simeticone->aluminium- and magnesium-containing antacids->aluminium
More informationReport generated from Joint Formulary provided by FormularyComplete (www.pharmpress.com). Accessed TA Number
Report generated from Joint Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 06 04 2017 Title Formulary Status Section TA Number TA Link Annotation ALUMINIUM HYDROXIDE Aluminium-only
More informationGASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease
Original Date of issue: 05/04/07 Last eviewed: 08/03/2013 Version: 5 Page 1 of 11 GASTO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease 1.1.1 Antacids and simeticone Magnesium Trisilicate
More informationChapter 1 Gastro-Intestinal System
Chapter 1 page number 1 Chapter 1 Gastro-Intestinal System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
More informationChapter 1 Gastro-Intestinal System
Chapter 1 page number 1 Chapter 1 Gastro-Intestinal System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
More information1. Gastro-intestinal system
1. Gastro-intestinal system Also see Appendix 1B Guidance on Management of Dyspepsia http://www.fifeadtc.scot.nhs.uk/formulary/1-gastro-intestinal/appendix-1b-management-ofdyspepsia.aspx Also see SIGN
More informationBNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13
BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 BNF 1.1 ANTACIDS Mucogel and Peptac are effective antacids and are available over the counter Gaviscon / Gaviscon Advance are available over the counter First
More informationBNF CHAPTER 1: GASTROINTESTINAL
BNF CHAPTER 1: GASTROINTESTINAL 1.1 DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE For symptomatic relief of hyperacidity, peptic ulcers, oesophagitis and acid reflux, liquids usually act faster than
More informationBNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM
BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 ANTACIDS Maalox and Peptac are effective antacids that can be bought Over the Counter for self-limiting symptoms. Choice Product Cost Effective Options &Comments
More informationBNF/BNFC Chapter 1 Gastro-intestinal System
NF/NF hapter 1 Gastro-intestinal System irections for questions 1 to 10. ach of the questions or incomplete statements in this section is followed by five suggested answers. Select the best answer in each
More informationGastrointestinal system
Gastrointestinal system Medicines Formulary Contents: 1. Dyspepsia and gastro-oesophageal disease 1 2. Acute gastrointestinal bleeding 2 3. Irritable bowel syndrome 3 4. Diarrhoea 3 5. Inflammatory bowel
More information1 Gastro-intestinal system
Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered
More information1 Gastro-intestinal system
Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered
More informationObjectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic
laxatives Hawler medical university Collage of pharmacy/ fourth stage /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical
More informationSecond term/
Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic
More informationASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use London, October 2007 Doc. Ref. EMEA/527934/2007 ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER The Paediatric Working Party
More informationSandwell and West Birmingham Hospitals NHS Trust
Sandwell and West Birmingham Hospitals NHS Trust Sandwell and West Birmingham Clinical Commissioning Group The drugs contained in the formulary of Sandwell and West Birmingham Hospitals Trust are listed
More informationConstipation. What is constipation? What causes constipation? How common is constipation?
Constipation What is constipation? Constipation is the word we use to describe any difficulty having a bowel movement. This does not just mean infrequent bowel movements, (two or fewer bowel movements
More informationMCA Training Made Easy
MCA Training Made Easy MODULE 8 Indigestion and Bowel Problems Learning objectives After reading this module you will: Understand the symptoms and causes of indigestion and heartburn and how to treat them
More informationA. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.
Pharmacology - Problem Drill 21: Drugs Used To Treat GI Disorders No. 1 of 10 1. Endogenous secretagogues for stomach acid include: #01 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Histamine
More informationPHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE
PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE Definition A circumscribed ulceration of the gastrointestinal mucosa occurring in areas exposed to acid and pepsin and most often caused
More informationDyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.
Antacids Hawler medical university Collage of pharmacy/ fourth year /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical
More informationPharmacology. Drugs that Affect the Gastrointestinal System
Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against
More information.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch.
.Drugs and the gastrointestinal system Chapter 11 11.1 Gastric acid-related conditions 149 11.2 Nausea and vomiting 153 11.3 Disorders of the bowel 155 11.4 Gallstones 156 Self-assessment on Chapter 11:
More informationReport generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed
Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 24 11 2017 This is a live document. Changes may have been made to the formulary since this report
More informationGateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area
Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Prescribing Committee formulary decisions Prepared by Pharmicus
More informationGastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D
Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:
More informationLab:2 Drugs acting on Gastrointestinal tract
Lab:2 Drugs acting on Gastrointestinal tract Drugs that used to treat three common medical conditions involving the gastrointestinal tract: peptic ulcers and gastroesophageal reflux disease (GERD), chemotherapy-induced
More informationGastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD
Formulary Book : Contents Subparagraph Page Nbr. 1.1.2.1 Gastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD 1.2 Gastro-intestinal system Antispasmod.&Other
More informationGateshead Formulary. Adapted with thanks from Formulary document prepared by Pharmicus
Gateshead Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Prescribing Committee formulary decisions Adapted with thanks from Formulary
More informationConstipation an Old Friend. Presented by Dr. Keith Harris
Constipation an Old Friend Presented by Dr. Keith Harris Irregularity and the Tricks of the Trade." CONSTIPATION What is constipation? INFREQUENT BOWEL MOVEMENTS DIFFICULTY DURING DEFECATION SENSATION
More information3.4 gram/7 gram powder -- $5.63
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Bowel Movements P&T DATE: 9/11/2018 CLASS: Gastrointestinal Disorders REVIEW HISTORY: 12/16, 9/15, 9/12, 5/08 LOB: MCL (MONTH/YEAR)
More informationNorth West London Integrated Formulary
North West London Integrated Formulary PUBLISHED VERSION (v15 02.04.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended
More informationSELF CARE AND OTC MEDICINES ON PRESCRIPTION
306 Medical Centre: SELF CARE AND OTC MEDICINES ON PRESCRIPTION NHS Southwark CCG no longer supports the routine prescribing on the NHS of medications for short term illnesses and minor conditions and
More informationAntidiarrheals Antidiarrheal
Antidiarrheals Major factors in diarrhea Increased motility of the GI tract. Decreased absorption of fluid. Antidiarrheal drugs include: Antimotility agents. Adsorbents. Drugs that modify fluid and electrolyte
More informationExamples of prices, license restrictions and availability of common over the counter medications.
Examples of s, license restrictions and availability of common over the counter medications. GSL items can be purchased from any er. Supermarkets and discount stores may be more cost effective than pharmacies.
More informationOmeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.
Omeprazole 10mg Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form omeprazole
More informationManaging constipation in adults with co-morbidities
Managing constipation in adults with co-morbidities Angela Gardiner and Andrea Hilton Constipation can be described in a number of ways but in general it is related to straining, reduced frequency of defecation
More informationGastrointestinal Pharmacology
Gastrointestinal Pharmacology Jan Kehr Department of Physiology and Pharmacology Gastrointestinal Pharmacology v Background v Peptic disorders v Constipation and Diarrhea v Chronic Bowel Disease Gastrointestinal
More informationNorth West London Integrated Formulary
North West London Integrated Formulary PUBLISHED VERSION (v14 05.02.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended
More informationGuidelines for the Management of Constipation: Adult Patients
Guidelines for the Management of Constipation: Adult Patients This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances
More informationNorth West London Integrated Formulary
North West London Integrated Formulary PUBLISHED VERSION (v19 19.11.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended
More informationGASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali
GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers
More informationThe management of constipation in adults
The management of constipation in adults Angela Gardiner and Andrea Hilton Abstract Definitions of constipation vary, but in general are related to straining at stool, reduced frequency of defecation and/or
More informationCare at the Chemist. Formulary
Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) For ages 2 years and over. Chloramphenicol 1% eye oint. (4g) For ages 2 years and over. Allergy Loratadine
More informationUsing Evidence Based Medicine to Ethically Provide End of Life Symptom Control
Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Erin Zimny, MD Emergency Medicine Hospice and Palliative Medicine Henry Ford Hospital Disclosures I do NOT have any financial
More informationDRUGS AFFECTING THE GASTROINTESTINAL SYSTEM
Page 1 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM SUNALI MEHTA Histamines and antihistamines: Histamine means tissue amine and is present in ample amount in the lung, skin and GI tract mucosa. Mast cells,
More informationCambridgeshire Community Pharmacy Minor Ailments Service. February 2009
Cambridgeshire Community Pharmacy Minor Ailments Service February 2009 Contents 3 Constipation & Paediatric Constipation 4 Diarrhoea & Paediatric Diarrhoea 5 Indigestion & Infant Gripes/Colic/Wind 6 Hay
More informationCare at the Chemist. Formulary
Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) Chloramphenicol 1% eye oint. (4g) Allergy Loratadine 10mg tablets (7) Sodium cromoglycate 2% eye drops
More informationLaxative Policy THIS POLICY MUST BE READILY ACCESSIBLE AT ALL TIMES AND AT THE POINT WHERE MEDICINES ARE USED.
Laxative Policy This is a working document and any changes that become necessary to this policy must be notified in writing to the Medicine Management Group via the Chief Pharmacist, East Cheshire Trust
More informationPrimary Care Constipation Guidelines. Version 1 November 2016
Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and
More informationOpioid constipation treatment dulcolax
P ford residence southampton, ny Opioid constipation treatment dulcolax Posts about how to relieve constipation instantly written by gbrese1958. Official Web site for MOVANTIK (naloxegol) tablets, for
More informationABC of palliative care: Constipation and diarrhoea
BMJ 1997;315:1293-1296 (15 November) Clinical review ABC of palliative care: Constipation and diarrhoea Marie Fallon, Bill O'Neill Prevalence of constipation Top Prevalence of constipation Assessment of
More informationNorth West London Integrated Formulary
North West London Integrated Formulary PUBLISHED VERSION (v28 23.04.2018) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended
More informationNorth West London Integrated Formulary
North West London Integrated Formulary PUBLISHED VERSION (v20 23.2.2016) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended
More informationHigh Resolution Oesophageal Manometry and 24 hour ph Monitoring. Information for patients
High Resolution Oesophageal Manometry and 24 hour ph Monitoring Information for patients A request has been sent to the GI Physiology Department to book an appointment for you to come to the Churchill
More informationPatient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4
Patient information Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 You have been diagnosed with laryngopharyngeal reflux (LPR), otherwise known as extra-oesophageal reflux
More informationDrugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility
Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many
More informationMosby items and derived items 2005, 2002 by Mosby, Inc. 1 Mosby items and derived items 2005, 2002 by Mosby, Inc. 2
CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN Types of Acid-Controlling Agents Antacids H 2 antagonists Proton pump inhibitors Mosby items and derived items 2005,
More informationProtectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry
Protectives and Adsorbents Inorganic chemistry Course 1 Third year 2016-2017 Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry Protectives and Adsorbents This group of gastrointestinal agents
More informationRpts. GENERAL General Schedule (Code GE)
Pantoprazole 20mg Name, Restriction, Manner of administration and form Pantoprazole 20mg enteric tablet, 30 (8399C) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form
More informationRpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives
Esomeprazole 20mg Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8886Q) (029W) Gastric ulcer Peptic ulcer Treatment Phase: Initial treatment The therapy must be for initial treatment
More informationPeptic ulcer disease Disorders of the esophagus
Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth
More informationGastro-intestinal System
CHAPTER 1 GASTRO-INTESTINAL SYSTEM 1.1 Nil by mouth patients drug administration Patients for investigations e.g. OGD (endoscopy): administer usual medicines with a sip of water caution with medicines
More informationAmitiza. Amitiza (lubiprostone) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.22 Subject: Amitiza Page: 1 of 5 Last Review Date: March 16, 2018 Amitiza Description Amitiza (lubiprostone)
More informationFormulary. 12 th Edition. Version14.1. May Eleanore Atkinson Medicines Information Pharmacist. Drug and Therapeutics Committee
Drug and Therapeutics Committee Formulary 12 th Edition Version14.1 May 2015 Compiled on behalf of the Drug and Therapeutics Committee by Eleanore Atkinson Medicines Information Pharmacist Formulary 12
More informationCopy right protected Page 1
DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.
More informationPage 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Acid reflux (gastroesophageal reflux disease) in adults (The Basics) Written by the doctors and editors at UpToDate
More informationFrequently Asked Questions Specific Medications
Medications to control inflammation are the single most important means of treating IBD. By bringing the inflammation under control, medications can relieve the symptoms of IBD and reduce the chances of
More informationDoncaster & Bassetlaw Medicines Formulary
Doncaster & Bassetlaw Medicines Formulary Section 1.5 Chronic Bowel Disorders (including IBD) Aminosalicylates: Mesalazine 400mg and 800mg MR Tablets (Octasa) Mesalazine 1.2g MR Tablets (Mezavant XL) Mesalazine
More informationWhat Is Constipation?
CONSTIPATION What Is Constipation? Constipation is when you have infrequent or hard-to-pass bowel movements (meaning they are painful or you have to strain), have hard stools or feel like your bowel movements
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 14 September 2011
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 14 September 2011 GAVISCON PEPPERMINT, chewable tablet B/20 (CIP code: 367 909-6) GAVISCON, oral suspension 250 ml
More informationDr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest)
EMA workshop on the development of new medicinal products for the treatment of ulcerative colitis and Crohn s disease Overview of authorised medicines for IBD in Europe - previous regulatory positions
More informationDrugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives
Drugs Affecting the Gastrointestinal System Antidiarrheal and Laxatives Diarrhea Abnormal frequent passage of loose stools or Abnormal passage of stools with increased frequency, fluidity, and weight,
More informationdaily; available as 10- mg g PO
Overview of the PRN: The Pain and Palliative Care PRN of ACCP is an organization of pharmacy practitioners, clinical scientists, pharmacy educators, and others. Its mission is to advance pain and palliative
More informationThis is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format.
This is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format. Part or all of this document may be printed from this file and distributed
More informationTreat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve
Treat primary symptoms Background information for clinicians Offer general lifestyle advice Background information for patients Manage IBS according to the dominant symptom Provenance Psychological symptoms
More informationOesophageal Manometry and 24 hour ph monitoring A guide to the test
n The Leeds Teaching Hospitals NHS Trust Oesophageal Manometry and 24 hour ph monitoring A guide to the test Information for patients This leaflet is intended to answer some of the questions you may have
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 October 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 20 October 2010 MEZAVANT LP 1200 mg, prolonged-release gastro-resistant tablets B/60 (CIP code: 378 689-2) Applicant
More informationGASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA
GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority
More informationMedical therapies and IBD
Medical therapies and IBD Although there is no cure for IBD, there are many treatment options available. There is no standard treatment for IBD that is effective in all situations or for all patients,
More informationGI Pharmacology. Dr. Alia Shatanawi 5/4/2018
GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Drugs Used in Gastrointestinal Diseases Drugs used in Peptic Ulcer Diseases. Drugs Stimulating Gastrointestinal Motility &Laxatives. Antidiarrheal Agents. Drugs
More informationGastrointestinal drugs
Gastrointestinal drugs Antacids and other antiulcer drugs Antacids (usually containing aluminium or magnesium compounds) can often relieve symptoms in ulcer dyspepsia and in non-erosive gastro-oesophageal
More information- Ali Yaghi. - Sara Yaghi. - Alia Shatnawi. 1 P a g e
-2 - Ali Yaghi - Sara Yaghi - Alia Shatnawi 1 P a g e We ended the previous lecture with H2 receptor antagonists, which work by selectively inhibiting H2 receptors. They are widely used to treat: 1- GERD,
More informationIrritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS) Dr Rex J Polson 17 th January 2018 Overview Description of the condition Discussion of symptoms and investigations that may be required Discussion of management and treatment
More informationProtocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians.
NY&AWC Medicines Management Team Protocol to support reducing the use of and the effective use of laxatives Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols
More informationCrohn s Disease. How does Crohn s disease affect the intestinal tract?
Crohn s Disease Crohn s disease is one of the two main forms of inflammatory bowel disease (IBD). The second main form of inflammatory bowel disease is ulcerative colitis. Crohn s disease causes inflammation
More informationConstipation. Myeloma Infosheet Series. Symptoms and complications. Infoline:
Constipation This Infosheet explains what constipation is, what causes it in myeloma patients, what the symptoms of it are, how it is treated and some tips for self-management. What is constipation? Constipation
More information24 Hour Ambulatory Impedance and ph Study. An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION 24 Hour Ambulatory Impedance and ph Study An information guide 24 Hour Ambulatory Impedance and ph Study IMPORTANT!! Please read section
More informationMEDICAL TERMS USED IN IBD
INFORMATION SHEET MEDICAL TERMS USED IN IBD INTRODUCTION You are likely to come across many new terms when you are diagnosed with Inflammatory. Bowel Disease. This information sheet explains some of the
More informationBowel Management, Community Nursing
CLINICAL GUIDELINE Bowel Management, Community Nursing A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on
More informationStep Therapy Approval Criteria
Effective Date: 01/01/2018 This document contains Step Therapy Approval Criteria for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab)
More informationPharmacy Services. The Forth Valley Minor Ailments Service Formulary. 2 nd edition
Pharmacy Services The Forth Valley Minor Ailments Service Formulary 2 nd edition December 2007 1 Contents Contact numbers 2 Introduction 3 How to use this formulary Acknowledgements Section 5 Skin 12 Acne
More informationEfficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club
Efficacy and Safety of Lubiprostone Laura Wozniak February 23, 2010 K30 Monthly Journal Club Objectives Brief overview of constipation Review of article Discussion Constipation in Children 3-5% of all
More informationPHARMA-MEDIC SERVICES INC. POLICY MANUAL
PHARMA-MEDIC SERVICES INC. POLICY MANUAL SUBJECT: INDEX: P.5.a.iii Automatic-Therapeutic Substitution DATE: June 1/2011 REVISED: March 2, 2015., Feb 2017. PROCEDURE: 1. Long term care homes use the Manitoba
More informationKingston Hospital NHS FoundationTrust and Kingston CCG. Joint Medicines Formulary
Kingston Hospital NHS FoundationTrust and Kingston CCG Joint Medicines Formulary Published Version 3 November 2013 Approved by Kingston CCG Medicines Management Committee Kingston Hospital NHS FoundationTrust
More informationMethadone Maintenance: safe and effective opioid pharmacotherapy. Karen Miotto, MD UCLA Department of Psychiatry
Methadone Maintenance: safe and effective opioid pharmacotherapy Karen Miotto, MD UCLA Department of Psychiatry Opioid abuse and dependence statistics, 2007 Persons who reported abuse or dependence in
More information